Human neonatal dendritic cells are competent in MHC class I antigen processing and presentation

Area of Science:

• Immunology
• Neonatal Immunity
• Cellular Immunology

Background:

• Neonates exhibit increased susceptibility to severe infections compared to adults.
• This heightened vulnerability is often attributed to immunological immaturity.
• The antigen processing and presentation capacity of neonatal dendritic cells (DCs) to CD8+ T cells is not well understood.

Purpose of the Study:

• To compare the antigen processing and presentation capabilities of neonatal and adult monocyte-derived dendritic cells (mo-DCs) via the MHC class I pathway.
• To investigate potential defects in neonatal DCs that could contribute to increased susceptibility to pathogens.

Main Methods:

• Utilized human CD8+ T cell clones to assess antigen presentation by neonatal and adult mo-DCs.
• Evaluated the presentation of antigenic peptides, HLA-E-restricted antigens, and MHC class I-restricted antigens.
• Assessed the processing and presentation of cell-associated antigens through cross-presentation via MHC class I.

Main Results:

• Neonatal mo-DCs demonstrated no functional defects in processing and presenting antigens via the MHC class I pathway.
• Specific functions assessed included peptide presentation, HLA-E-restricted antigen presentation, classical MHC class I antigen processing and presentation, and cross-presentation.

Conclusions:

• The major histocompatibility complex (MHC) class I antigen processing and presentation pathway is fully functional in neonatal dendritic cells.
• Neonatal immune immaturity in MHC class I antigen processing and presentation is unlikely to be the primary cause of diminished pathogen control in neonates.